DILTIAZEM HYDROCHLORIDE (diltiazem hydrochloride) by Dr. Reddy's Laboratories is mechanism of action diltiazem hydrochloride extended-release capsules produces its antihypertensive effect primarily by relaxation of vascular smooth muscle and the resultant decrease in peripheral vascular resistance. Approved for hypertension. First approved in 2022.
Drug data last refreshed 18h ago
Mechanism of Action Diltiazem Hydrochloride Extended-Release Capsules produces its antihypertensive effect primarily by relaxation of vascular smooth muscle and the resultant decrease in peripheral vascular resistance. The magnitude of blood pressure reduction is related to the degree of…
Worked on DILTIAZEM HYDROCHLORIDE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo